Maven Bio is transforming how BioPharma teams analyze markets and evaluate therapeutic opportunities. By integrating purpose-built generative AI models with a curated, continuously updated biopharma database, we help consultants, investors, and corporate teams rapidly turn questions into strategic decisions—reducing manual effort and accelerating insights.

Recently, we closed a $3.1M seed round led by renowned investors including Pags Group, Splash Capital, NVO Group, and Y Combinator. Our fast-growing customer base includes public biopharma companies such as DayOne and leading consultancies like ZS Associates.

Our platform provides four core capabilities:

• Maven Workflows: Streamline research through AI-assisted structured tasks, delivering insights with confidence.

• Maven Atlas: Access comprehensive, pre-built indication landscapes or instantly create customized analyses.

• Maven Compass: Quickly generate targeted lists of companies, drugs, trials, or documents using AI-enhanced filtering.

• Maven Assistant: Obtain immediate, source-linked answers to critical BioPharma questions.

At Maven Bio, you'll be part of a high-performing, experienced team reshaping BioPharma intelligence with cutting-edge AI solutions.